Similar articles

• Tenofovir Gel to Prevent HSV-2 Infection.

  Feder HM Jr. Feder HM Jr. N Engl J Med. 2015 Nov 12;373(20):1980. doi: 10.1056/NEJMc1511338. N Engl J Med. 2015. PMID: 26559585 No abstract available.
• Tenofovir Gel to Prevent HSV-2 Infection.

  Abdool Karim SS, Abdool Karim Q, Gengiah TN. Abdool Karim SS, et al. N Engl J Med. 2015 Nov 12;373(20):1980-1. doi: 10.1056/NEJMc1511338. N Engl J Med. 2015. PMID: 26559584 No abstract available.
• Pericoital application of tenofovir gel reduced risk for herpes simplex virus type 2 in HIV-negative women.

  Baang J. Baang J. Ann Intern Med. 2015 Dec 15;163(12):JC6. doi: 10.7326/ACPJC-2015-163-12-006. Ann Intern Med. 2015. PMID: 26666808 No abstract available.
• Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection.

  Abdool Karim SS, Abdool Karim Q, Kharsany AB, Baxter C, Grobler AC, Werner L, Kashuba A, Mansoor LE, Samsunder N, Mindel A, Gengiah TN; CAPRISA 004 Trial Group. Abdool Karim SS, et al. N Engl J Med. 2015 Aug 6;373(6):530-9. doi: 10.1056/NEJMoa1410649. N Engl J Med. 2015. PMID: 26244306 Free PMC article. Clinical Trial.
• Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.

  Friend DR. Friend DR. Expert Opin Drug Deliv. 2012 Apr;9(4):417-27. doi: 10.1517/17425247.2012.668183. Epub 2012 Mar 2. Expert Opin Drug Deliv. 2012. PMID: 22385316 Review.